Zobrazeno 1 - 10
of 143
pro vyhledávání: '"David S Geldmacher"'
Autor:
Reed W R Bratches, Jaclyn A Wall, Frank Puga, Giovanna Pilonieta, Rita Jablonski, Marie Bakitas, David S Geldmacher, J Nicholas Odom
Publikováno v:
JMIR Aging, Vol 6, Pp e44166-e44166 (2023)
Abstract BackgroundFamily caregivers are often inexperienced and require information from clinic visits to effectively provide care for patients. Despite reported deficiencies, 68% of health systems facilitate sharing information with family caregiv
Externí odkaz:
https://doaj.org/article/1e2fa4f8b83b4b2fb8e4632ca1e72554
Autor:
Gene E Alexander, Lee eRyan, Dawn eBowers, Thomas C Foster, Jennifer L Bizon, David S Geldmacher, Elizabeth L Glisky
Publikováno v:
Frontiers in Aging Neuroscience, Vol 4 (2012)
With the population of older adults expected to grow rapidly over the next two decades, it has become increasingly important to advance research efforts to elucidate the mechanisms associated with cognitive aging, with the ultimate goal of developing
Externí odkaz:
https://doaj.org/article/33a71587dbb94376aa3b5cf0690507a1
Publikováno v:
Frontiers in Aging Neuroscience, Vol 4 (2012)
Characterizing the cognitive declines associated with aging, and differentiating them from the effects of disease in older adults, are important goals for human neuroscience researchers. This is also an issue of public health urgency in countries wit
Externí odkaz:
https://doaj.org/article/b4c7633acd8a4927841de8d2db918ff6
Autor:
Giovanna Pilonieta, Maria Pisu, Roy C. Martin, Liang Shan, Richard E. Kennedy, Gabriela Oates, Young-Il Kim, David S. Geldmacher
Publikováno v:
Journal of Alzheimer's Disease. :1-11
Background: Access to specialists facilitates appropriate Alzheimer’s disease and related dementia (ADRD) medication use and adherence. However, there is little information on the impact of specialists’ availability on ADRD medication adherence,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d076f8b28196221b959a6d1cb70356c
https://doi.org/10.3233/jad-220620
https://doi.org/10.3233/jad-220620
Autor:
Sara A. Nolin, Hannah Cowart, Stacy Merritt, Katalina McInerney, P. K. Bharadwaj, Mary Kate Franchetti, David A. Raichlen, Cortney J. Jessup, G. Alex Hishaw, Emily J. Van Etten, Theodore P. Trouard, David S. Geldmacher, Virginia G. Wadley, Eric S. Porges, Adam J. Woods, Ron A. Cohen, Bonnie E. Levin, Tatjana Rundek, Gene E. Alexander, Kristina M. Visscher
Publikováno v:
Journal of the International Neuropsychological Society. :1-10
Objective: To evaluate the construct validity of the NIH Toolbox Cognitive Battery (NIH TB-CB) in the healthy oldest-old (85+ years old). Method: Our sample from the McKnight Brain Aging Registry consists of 179 individuals, 85 to 99 years of age, sc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::306a6cbb6b45f1f330e0b03ba442318b
https://doi.org/10.1017/s1355617722000443
https://doi.org/10.1017/s1355617722000443
Autor:
Carter A. Wright, Jared W. Taylor, Meagan Cochran, James M.J. Lawlor, Belle A. Moyers, Michelle D. Amaral, Zachary T. Bonnstetter, Princess Carter, Veronika Solomon, Richard M. Myers, Marissa Natelson Love, David S. Geldmacher, Sara J. Cooper, Erik D. Roberson, J. Nicholas Cochran
Publikováno v:
medRxiv
We collected and analyzed genomic sequencing data from individuals with clinician- diagnosed early-onset or atypical dementia. Thirty-two patients were previously described, with sixty-eight newly described in this report. Of those sixty-eight, sixty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17720649a22487298874f8bd9160d67c
https://doi.org/10.1101/2023.02.06.23285383
https://doi.org/10.1101/2023.02.06.23285383
Autor:
Joshua Grill, Tyler Berkness, Maria C. Carrillo, Heather M. Snyder, Paul Aisen, Reisa A. Sperling, Ronald C. Petersen, Neelum T. Aggarwal, Karen L. Bell, Jeffrey M. Burns, Michael C. Donohue, Hiroko H Dodge, Mark A. Espeland, Daniel L. Gillen, David S. Geldmacher, Judith L Heidebrink, Gregory A Jicha, John M. Olichney, Michael S Rafii, Dorene M. Rentz, Stephen P. Salloway, Gopalan Sethuraman, Amanda G Smith, Rema Raman
Publikováno v:
Alzheimer's & Dementia. 18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ce19d765b37508f80fb7f1929ae9634
https://doi.org/10.1002/alz.064617
https://doi.org/10.1002/alz.064617
Autor:
Lisa Roberts, Ellen L. Brown, Marc E. Agronin, Monica Strauss Hough, David S. Geldmacher, Xin Yang, C Victoria Framil, Peter Clarke, Nicole Ruggiano, Debra Davis, Mariateresa Teri H Muñoz
Publikováno v:
Res Gerontol Nurs
Alzheimer's disease and related dementias (ADRD) often result in communication deficits that can lead to negative health outcomes as well as complications for caregiving and clinical care. Although augmentative and alternative communication (AAC) dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eff9ee0f5a16398dbd85061cb3970e8d
https://doi.org/10.3928/19404921-20210825-02
https://doi.org/10.3928/19404921-20210825-02
Autor:
Richard G. Stefanacci, S. Seleri Assunção, J. Susman, S. A. Brunton, C. K. Clevenger, W. C. Jackson, S. F. Candela, Alireza Atri, Jacobo Mintzer, Valerie T. Cotter, Devangere P. Devanand, Marwan N. Sabbagh, Howard Fillit, Gary W. Small, Jeffrey L. Cummings, George T. Grossberg, David S. Geldmacher, A. Wise-Brown, Diana R. Kerwin, J. L. Liss, Tobias Bittner
Publikováno v:
Journal of Internal Medicine. 290:310-334
The critical role of primary care clinicians (PCCs) in Alzheimer's disease (AD) prevention, diagnosis and management must evolve as new treatment paradigms and disease-modifying therapies (DMTs) emerge. Our understanding of AD has grown substantially
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c173cc1c68c17bec78c2f8bd1ac765ac
https://doi.org/10.1111/joim.13244
https://doi.org/10.1111/joim.13244
Autor:
Wassilios G. Meissner, Roberto Eleopra, Taku Hatano, Francisco Grandas, Joseph F. Quinn, Justyna Sarna, Hui Zheng, Osamu Onodera, John T. Slevin, Theresa A. Zesiewicz, Anwar Ahmed, Erika Driver-Dunckley, Tao Xie, Hidek Mochizuki, Deborah A. Hall, John O`Sullivan, Peter A. Ljubenkov, Carlo Colosimo, Tomoko Oeda, Luc Defebvre, Diana R. Kerwin, Hana Florian, Deli Wang, Hoi-Kei Lon, David S. Geldmacher, Nahome Fisseha, Jennifer Hui, Elizabeth Peckham, Noriko Nishikawa, Jean-Christophe Corvol, Günter U. Höglinger, Jared Brosch, Fabienne Ory-Magne, Alberto Albanese, Kumar Budur, Yvette Bordelon, Zbigniew K. Wszolek, Stefano Ruggieri, Akio Kikuchi, James H. Bower, Kelly Bertram, Antonio Daniele, Daryl Wile, Ikuko Aiba, Rajeev Kumar, Lawrence S. Honig, Daniel Claassen, Victor S.C. Fung, Renato P. Munhoz, Beatrice Rendenbach-Mueller, Michael Gold, Ziyi Jin, Albert C. Ludolph, Nuno Mendonca, Ronald B. Postuma, John C. Morgan, Alexandre Eusebio, Aldo Quattrone, Antoine Duquette, Pablo Mir Rivera, Irene Litvan, Thomas E. Kimber, Michele Tagliati, Paola Cudia, Stefan Lorenzl, Takashi Kimura, Zoltan Mari, Hideki Oizumi, Nikolaus R. McFarland, Davis C. Ryman, Lawrence I. Golbe, Paul E Schulz
Publikováno v:
The lancet / Neurology 20(3), 182-192 (2021). doi:10.1016/S1474-4422(20)30489-0
Summary Background Progressive supranuclear palsy is a neurodegenerative disorder associated with tau protein aggregation. Tilavonemab (ABBV-8E12) is a monoclonal antibody that binds to the N-terminus of human tau. We assessed the safety and efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35a58b45d2df91f5a39e5802eb0fcc0d
https://doi.org/10.1016/s1474-4422(20)30489-0
https://doi.org/10.1016/s1474-4422(20)30489-0